is ghk-cu injection safe safety clinical trial ghk-cu injection safety evidence GHK-Cu

These are laboratory observations, not personal-outcome predictions

alkyl thiomaltosides, such as heptyl-, octyl-, dodecyl-, tridecyl-, and tetradecyl-g-D-thio alkyl thiosucroses which may be synthesized according to, for example, Binder, T

Food and Drug Administration (FDA) Symptoms to watch for include rapid breathing, extreme fatigue, irregular heartbeat, cold sensations in the extremities, muscle pain, and abdominal discomfort

A 2025 meta-analysis pooling three trials (878 participants) confirmed the pattern: significantly greater weight loss than placebo about ~14% of total body weight on average with no significant rise in overall adverse events [6] [7]

If you would like to submit a receipt to your insurance provider for possible out-of-network reimbursement, we can provide an itemized receipt upon request at time of service